Etoposide (VP-16-213). Current status of an active anticancer drug.
O'Dwyer
P J
PJ
Leyland-Jones
B
B
Alonso
M T
MT
Marsoni
S
S
Wittes
R E
RE
D000818:Animals; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004247:DNA / Q000378:metabolism; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D005047:Etoposide / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D051379:Mice; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013736:Testicular Neoplasms / Q000188:drug therapy; D014018:Tissue Distribution
D005047:Etoposide; D004247:DNA; D011034:Podophyllotoxin